IgA rheumatoid factor in primary Sjögren's syndrome

References

• Jonsson R., Haga H‐J., Gordon T. Sjögren's syndrome. Arthritis and allied conditions – a textbook of rheumatology, 14th edn, W. J Koopman. Lippincott Williams & Wilkins, Philadelphia 2001; 1736–59
   Google Scholar
• Manthorpe R., Bredberg A., Henriksson G., Larsson A. Progress and regression within Sjögren's syndrome. Scand J Rheumatol 2006; 35: 1–6
   PubMed Web of Science ®Google Scholar
• Markusse H. M., Otten H. G., Vroom T. M., Smeets T. J., Fokkens N., Breedveld F. C. Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome. Clin Immunol Immunopathol 1993; 66: 26–32
   PubMedGoogle Scholar
• Otten H. G., Daha M. R., van der Maarl M. G., Hoogendoorn L. I., Beem E. M., de Rooy H. H., et al. IgA rheumatoid factor in mucosal fluids and serum of patients with rheumatoid arthritis: immunological aspects and clinical significance. Clin Exp Immunol 1992; 90: 256–9
   PubMedGoogle Scholar
• Muller K., Oxholm P., Mier‐Madsen M., Wiik A. Circulating IgA‐ and IgM‐rheumatoid factors in patients with primary Sjögren syndrome. Correlation to extraglandular manifestations. Scand J Rheum 1989; 18: 29–31
   PubMed Web of Science ®Google Scholar
• Elkon K. B., Gharavi A., Hughes G. R. V., Moutsopoulos H. M. Autoantibodies in the sicca syndrome (primary Sjögren's syndrome). Ann Rheum Dis 1984; 43: 243–5
   PubMed Web of Science ®Google Scholar
• Atkinson J. C., Travis W. D., Slocum L., Ebbs W. L., Fox P. C. Serum anti‐SS‐B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome. Arthritis Rheum 1992; 35: 1368–72
   PubMed Web of Science ®Google Scholar
• Jonsson T., Valdimarsson H. Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Rheumatol Int 1992; 12: 111–13
   PubMed Web of Science ®Google Scholar
• Jonsson T., Arinbjarnarson S., Thorsteinsson J., Steinsson K., Geirsson A. J., Jonsson H., et al. Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra‐articular manifestations in rheumatoid arthritis. Scand J Rheumatol 1995; 24: 372–5
   PubMed Web of Science ®Google Scholar
• Teitsson I., Teitsson H. M., Hernandez L. A., Sturrock R. D. IgA and IgM rheumatoid factors (RF) in established rheumatoid arthritis (RA): relationship to activity and radiological severity. Scand J Rheumatol 1986; Suppl 59:abstract F II 3:: 72
   Google Scholar
• Eberhardt K. B., Truedsson L., Petterson H., Petterson H., Svensson B., Stigsson L., et al. Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor. Ann Rheum Dis 1990; 49: 906–9
   PubMed Web of Science ®Google Scholar
• Vitali C., Bombardieri S., Moutsopoulos H. M., Balestrieri G., Benavelli W., Bernstein R. M., et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of an EEC prospective concerted action. Arthritis Rheum 1993; 36: 340–7
   PubMed Web of Science ®Google Scholar
• Greenspan J. S., Daniels T. E., Talal N., Sylvester R. A. The histopathology of Sjögren's syndrome in labial salivary biopsies. Oral Surg 1974; 37: 217–29
   PubMedGoogle Scholar
• Kleveland G., Egeland T., Lea T. Quantitation of rheumatoid factor (RF) and IgM, IgA, and IgG isotypes by a simple and sensitive ELISA. Discrimination between false and true IgG‐RF. Scand J Rheumatol 1988; Suppl 75: 15–24
   Google Scholar
• Daniels T. E. Sjögren's syndrome: clinical spectrum and current diagnostic controversies. Adv Dent Res 1996; 10: 3–8
   PubMedGoogle Scholar
• Tengner P., Halse A. K., Haga H. J., Jonsson R., Wahren‐Herlenius M. Detection of anti‐Ro/SSA and anti‐La/SSB autoantibody‐producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 1998; 41: 2238–48
   PubMed Web of Science ®Google Scholar
• Aaserod K., Haga H. J., Berg K. J., Hammerstrom J., Jorstad S. Renal involvement in primary Sjögren's syndrome. Q J Med 2000; 93: 297–304
   Google Scholar
• Shioji R., Furuyama T., Onodera S., Saito H., Ito H., Sosoki Y. Sjögren's syndrome and renal tubular acidosis. Am J Med 1970; 48: 456–63
   PubMed Web of Science ®Google Scholar
• Gripenberg M., Teppo A. M., Kurki P., Gripenberg G., Helve T. Autoantibody activity of cryoglobulins and sera in systemic lupus erythematosus. Scand J Rheum 1988; 17: 249–54
   PubMed Web of Science ®Google Scholar
• Blackburn W. D., Koopman W. J., Schrohenloher R. E., Heck L. W. Induction of neutrophil enzyme release by rheumatoid factors: evidence for differences based on molecular characteristics. Clin Immunol Immunopathol 1986; 40: 347–55
   PubMedGoogle Scholar
• Sabharwal U. K., Vaughan J. H., Fong S., Bennett P. H., Carson D. A., Curd J. G. Activation of the classical pathway of complement by rheumatoid factors. Arthritis Rheum 1982; 25: 161–7
   PubMedGoogle Scholar
• Haga H. J., Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome. J Rheumatol 1999; 26: 1291–5
   PubMedGoogle Scholar
• Sabharwal P., Glaser R., Lafuse W., Varma S., Liu Q., Arkins S., et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 1992; 89: 7713–16
   PubMed Web of Science ®Google Scholar
• Neidhart M. Prolactin in autoimmune diseases. Proc Soc Exp Med 1998; 217: 899–906
   Google Scholar
• Haga H‐J., Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjögren's syndrome. Scand J Rheumatol 1999; 28: 227–32
   PubMed Web of Science ®Google Scholar